new
betacoronaviru
name
emerg
new
threat
global
health
economi
promis
target
diagnosi
therapeut
treatment
new
diseas
name
coronaviru
cov
spike
glycoprotein
constantph
mont
carlo
simul
proceedpka
method
map
electrostat
epitop
four
monoclon
antibodi
angiotensinconvert
enzym
new
receptor
bind
domain
rbd
protein
also
calcul
free
energi
interact
shown
rbd
protein
sar
virus
bind
similar
affin
howev
affin
rbd
protein
new
higher
studi
antibodi
previous
found
complex
base
physic
chemic
analysi
free
energi
estim
shed
light
involv
molecular
recognit
process
clinic
aspect
implic
drug
develop
suggest
structur
modif
antibodi
would
improv
bind
affin
contribut
address
ongo
intern
health
crisi
viru
recent
found
wuhan
hubei
provinc
china
offici
name
world
health
organ
alreadi
spread
china
contin
countri
confirm
case
global
death
data
report
central
european
time
april
due
pandem
diseas
affect
health
servic
also
economi
global
scale
interf
widespread
displac
peopl
tourism
local
even
intern
market
china
economi
worldwid
refer
disrupt
lead
global
impact
suppli
chain
product
coronavirida
famili
belong
includ
larg
variabl
virus
becam
recogn
spring
human
coronaviru
caus
sever
acut
respiratori
syndrom
sar
base
phylogenet
analysi
classifi
lineag
b
betacoronaviru
belong
group
bat
coronaviru
demonstr
wide
similar
genet
sequenc
ident
transmiss
confirm
humantohuman
sever
medic
care
personnel
rel
got
infect
believ
start
anim
host
may
bat
anoth
intermedi
host
even
though
viru
usual
caus
sever
damag
bodi
explain
major
concern
high
infect
pathogen
diseas
caus
viru
gener
caus
mild
upper
respiratori
tract
infect
result
fever
cough
yet
also
affect
lower
effect
neutral
ab
relev
futur
prevent
treatment
widespread
ill
immedi
control
end
new
design
mab
candid
propos
base
present
silico
find
comput
virolog
emerg
research
field
take
advantag
progress
molecular
structur
biolog
immunolog
bioinformat
relat
area
foster
understand
viru
evolutionari
dynam
natur
infect
pathogenesi
cellhosttrop
viral
assembl
molecular
interact
gener
includ
predict
epitop
design
specif
neutral
antibodi
basic
drug
design
discoveri
relat
viral
infect
particular
structur
interact
aspect
benefit
solid
foundat
comput
molecular
simul
method
molecular
dynam
md
mont
carlo
mc
achiev
probe
thermodynam
dynam
interact
properti
biomolecul
materi
scienc
food
pharma
see
ref
review
appli
fast
constantph
mc
scheme
proteinprotein
studi
improv
understand
molecular
interact
involv
rbd
protein
identifi
key
amino
acid
hostpathogen
interact
sever
molecular
system
investig
present
studi
employ
two
rbd
protein
see
figur
fragment
mab
typic
fragment
mab
fusion
protein
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
variabl
region
heavi
light
chain
immunoglobulin
connect
short
linker
peptid
addit
calcul
carri
rbd
new
propos
mab
base
macromolecul
three
dimension
crystallograph
structur
avail
rcsb
protein
data
bank
pdb
rbd
protein
extract
pdb
id
chain
e
resolut
ph
found
complex
chain
see
figur
b
fragment
ab
taken
pdb
id
chain
b
resolut
ph
c
ab
extract
pdb
id
chain
b
resolut
ph
remov
part
chain
keep
variabl
region
short
linker
peptid
fab
taken
pdb
id
chain
l
c
resolut
ph
follow
procedur
use
miss
region
protein
built
use
ucsf
chimera
interfac
program
model
default
paramet
figur
show
final
threedimension
structur
use
work
pdb
file
edit
calcul
water
molecul
hetero
atom
complet
remov
use
file
ucsf
chimera
packag
employ
molecular
visual
represent
studi
start
experiment
structur
avail
rbd
protein
model
built
swissmodel
workspac
base
ncbi
refer
sequenc
rootmeansquar
deviat
rmsd
atom
posit
model
structur
rbd
protein
avail
one
pdb
id
structur
comparison
rbd
protein
sar
virus
seen
figur
recent
new
experiment
structur
solv
exampl
cryoem
structur
avail
prefus
glycoprotein
singl
incomplet
rbd
pdb
id
resolut
rmsd
model
rbd
chain
structur
number
closer
rmsd
differ
two
chain
experiment
pdb
id
trimer
structur
eg
chain
x
chain
b
chain
x
chain
c
divers
possibl
conform
might
motiv
studi
explor
effect
theoret
predict
rmsd
valu
also
indic
model
structur
viru
use
reason
within
expect
conform
fluctuat
structur
could
chosen
work
moreov
intrins
assumpt
experiment
structur
obtain
given
specif
physic
chemic
condit
ionic
strength
ph
concentr
etc
valid
anoth
condit
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
standard
amino
acid
chain
e
rbd
shown
molecular
represent
use
sphere
atom
atom
color
accordingli
amino
acid
physic
chemic
properti
red
acid
amino
acid
blue
base
amino
acid
gray
nontitr
amino
acid
better
visual
interfac
structur
translat
particularli
success
neutral
human
mab
first
isol
convalesc
patient
ter
meulen
coauthor
present
studi
three
dimension
structur
see
figur
built
swissmodel
workspac
fragment
mab
pdb
id
modeledse
text
detail
pdb
id
pdb
id
shown
ribbon
represent
larg
divers
model
avail
md
mc
molecular
simul
need
repeat
calcul
sever
differ
physic
chemic
condit
obtain
free
energi
interact
drive
option
socal
costeffect
coarsegrain
cg
model
cg
model
offer
possibl
explor
main
physic
featur
system
reduc
number
paramet
lower
comput
cost
last
year
fast
constantph
cph
cg
model
devis
success
studi
proteinprotein
interact
sever
biolog
system
includ
hostpathogen
interact
possibl
fulli
consid
ph
effect
make
model
approach
appeal
appropri
address
problem
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
sketch
simul
model
given
figur
rbd
protein
fragment
mab
model
rigid
bodi
ie
bond
length
angl
dihedr
angl
kept
fix
form
set
amino
acid
place
posit
given
threedimension
structur
describ
addit
approxim
justifi
prohibit
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
comput
cost
constantph
method
phdepend
conform
chang
moreov
known
protein
exhibit
larg
conform
chang
upon
bind
least
group
atom
defin
amino
acid
convert
singl
charg
lennardjon
lj
sphere
radiu
ri
valenc
zi
cg
process
turn
protein
atomist
structur
collect
charg
lj
particl
repres
amino
acid
centersofmass
bead
mimick
amino
acid
use
place
accordingli
coordin
given
threedimension
structur
valu
ri
type
amino
acid
taken
ref
valenc
ioniz
residu
function
solut
ph
fast
proton
titrat
scheme
fpt
employ
initi
assign
valenc
amino
acid
let
vari
simul
sampl
given
ph
method
prove
predict
good
accuraci
low
comput
cost
fundament
physic
chemic
basi
titrat
scheme
numer
implement
benchmark
discuss
relat
approxim
pro
con
found
previou
public
illustr
figur
two
protein
place
electroneutr
open
cylindr
simul
box
free
translat
back
forward
along
axi
center
lay
rotat
direct
titrat
exampl
two
protein
model
three
dimension
structur
rbd
crystallograph
structur
fragment
mab
unless
otherwis
specifi
simul
run
carri
cell
radiu
rcyl
height
lcyl
equal
respect
static
dielectr
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
constant
set
assum
temperatur
counterion
ad
salt
particl
repres
implicitli
use
screen
term
ie
two
ioniz
amino
acid
j
screen
given
exp
modifi
invers
deby
length
rij
interparticl
separ
distanc
addit
simplifi
simul
box
one
protein
present
use
character
titrat
properti
singl
macromolecul
electrostat
interact
two
ioniz
amino
acid
valenc
given
proteinprotein
interact
also
control
physic
contribut
van
der
waal
interact
hydrophob
effect
exclud
volum
repuls
simpl
effect
way
includ
effect
mean
lj
term
uvdw
rij
bead
amino
acid
mathemat
two
bead
charg
neutral
one
j
uvdw
rij
given
ri
rj
separ
distanc
two
amino
acid
j
contact
instanc
pair
valglu
rval
rglu
rval
rglu
ref
possibl
use
differ
size
bead
allow
incorpor
non
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
specif
contribut
hydrophob
effect
model
preserv
macromolecular
hydrophob
moment
contribut
guid
correct
dock
orient
short
separ
distanc
term
regul
strength
attract
forc
system
typic
assum
univers
biomolecular
system
equal
kjmol
correspond
hamak
constant
ca
kb
kg
k
boltzmann
constant
temperatur
kelvin
amino
acid
pair
howev
valu
might
result
underestim
attract
depend
biomolecular
system
instanc
equal
valu
time
greater
kjmol
necessari
reproduc
experiment
data
adsorpt
hydrophil
silica
surfac
convers
lactoglobulinlactoferrin
complex
seem
overestim
usual
valu
consequ
research
strategi
adopt
consensu
valu
kjmol
also
impli
outcom
interpret
rel
caution
bear
mind
intrins
approach
assum
model
direct
impact
seen
free
energi
deriv
discuss
later
result
section
combin
eq
total
system
interact
energi
given
configur
written
amino
acid
posit
total
number
includ
charg
neutral
bead
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
endosom
furthermor
seem
controversi
experiment
work
acidif
essenti
uptak
cellfre
sar
viru
exact
valu
acid
ph
condit
unknown
made
choic
use
ph
valu
crystallograph
environ
acid
among
studi
structur
ph
pdb
id
also
made
possibl
easili
investig
behavior
system
intermedi
condit
interpol
present
outcom
proper
equilibr
simul
molecular
system
long
product
run
carri
simul
whose
focu
titrat
properti
z
ph
pka
requir
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
interfac
antibodyantigen
peculiar
electrostat
pattern
richer
titrat
group
differ
gener
proteinprotein
interfac
etc
fact
contribut
shift
canon
view
lock
key
clear
focu
protein
surfac
broader
definit
led
electrostat
epitop
ee
concept
mean
inner
titrat
group
one
epitopeparatop
interfac
also
particip
interplay
interact
ab
ee
core
idea
proceedpka
method
pka
shift
use
identifi
key
amino
acid
respons
hostpathogen
associ
appli
fact
locat
shift
practic
mean
probe
molecular
interact
demonstr
moreov
easili
measur
comput
simul
proteinprotein
complex
predict
properti
power
tool
previous
statist
analyz
flavivirus
ii
compar
bioinformat
tool
often
ignor
ph
ionic
strength
drastic
affect
complex
process
iii
discuss
detail
preced
work
capac
method
test
ee
specif
mab
make
even
appeal
present
studi
four
known
mab
investig
sake
conveni
predict
ee
studi
system
graphic
compar
sequenc
level
pairwis
sequenc
align
gener
server
emboss
needl
default
set
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
one
central
question
understand
patholog
includ
high
transmiss
possibl
therapeut
intervent
control
epidem
spread
deciph
prevent
molecular
interact
protein
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
differ
could
due
sever
reason
includ
experiment
uncertainti
report
tian
work
contrast
result
anoth
recent
studi
advoc
greater
bind
affin
even
present
theoret
previous
report
experiment
data
agre
rbd
rbd
similar
attract
high
bind
affin
impli
human
organ
rich
oral
nasal
mucosa
lung
stomach
small
intestin
colon
skin
lymph
node
thymu
bone
marrow
spleen
liver
kidney
brain
easili
infect
clear
opportun
viru
lung
alveolar
epitheli
cell
enterocyt
small
intestin
abund
note
simul
perform
singl
rbd
protein
absenc
full
structur
protein
other
two
chain
homotrimer
glycoprotein
bring
evid
structur
part
subunit
subunit
two
chain
essenti
individu
pair
complex
also
observ
support
argument
dissoci
subunit
complex
happen
without
interrupt
infect
also
allow
subunit
transit
metast
prefus
postfus
state
second
step
viral
infect
ph
closer
low
ph
occur
outsid
cell
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
freeenergi
landscap
must
interpret
care
alreadi
point
one
side
use
simpl
thermodynam
criterion
neg
free
energi
valu
would
result
molecular
complex
convers
free
energi
valu
smaller
thermal
energi
kbt
would
indic
unstabl
associ
observ
differ
two
rdb
protein
greater
estim
statist
error
howev
prefer
interpret
small
differ
tendenc
system
base
previou
studi
observ
either
comput
complex
weaker
experiment
measur
much
stronger
feel
safer
use
data
other
discuss
rel
term
ie
compar
differ
situat
allow
us
success
predict
experiment
observ
respect
limit
cg
model
similar
free
energi
minima
rel
amplifi
ph
seen
comparison
ph
viral
rbd
protein
affin
slightli
rais
ph
increas
acid
neutral
regim
somewhat
higher
bind
affin
neutral
ph
suggest
role
ph
rbd
protein
constantli
debat
literatur
might
critic
infect
also
reinforc
possibl
viral
cell
invas
phdepend
process
inde
seem
ph
relev
next
step
continu
viral
infect
first
entri
level
possibl
non
phdepend
process
might
increas
opportun
sar
virus
easili
infect
cell
therefor
contribut
high
infect
might
limit
use
chloroquin
effici
drug
sinc
first
action
increas
cell
ph
least
neutral
ph
solut
prevent
bind
rbd
opposit
favor
affin
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
anoth
import
aspect
evalu
put
mab
could
bind
rbd
new
follow
work
tian
collabor
investig
interact
two
sar
rbd
protein
potent
rbd
specif
neutral
antibodi
figur
show
free
energi
profil
acid
regim
physiolog
salt
condit
studi
fragment
ab
rel
stronger
attract
alway
observ
rbd
protein
interact
mab
better
seen
figur
moreov
work
tian
coauthor
suggest
experiment
measur
reason
bind
combin
inform
could
indic
threshold
use
better
refin
theoret
bind
predict
macromolecular
complex
ie
viral
proteinprotein
system
valu
smaller
expect
experi
bind
vivo
least
tabl
summar
valu
given
parenthesi
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
next
explor
basic
physic
chemic
aspect
could
offer
simpl
quick
reason
understand
free
energi
result
eventu
use
descriptor
scan
databas
mab
filter
promis
ideal
candid
although
differ
driven
forc
result
proteinprotein
complex
ph
chargecharg
interact
seem
especi
import
viral
protein
inde
protein
net
charg
number
z
obtain
function
solut
ph
show
rdb
protein
alway
slightli
posit
charg
rdb
protein
physic
chemic
environ
z
equal
respect
ph
see
tabl
sinc
studi
fragment
ab
also
posit
charg
ph
z
equal
respect
easili
seen
order
observ
bind
affin
free
energi
analys
follow
simpl
chargecharg
rule
mab
similar
surfac
area
rdb
protein
weaker
stronger
repuls
case
term
coulomb
contribut
zi
zj
assum
bjerrum
length
salt
screen
separ
distanc
predict
order
bind
affin
agre
previou
free
energi
analys
see
larg
larger
attract
van
der
waal
interact
overcom
chargecharg
repuls
also
explain
smaller
roughli
half
less
attract
rbd
protein
even
slightli
less
posit
charg
z
equal
ph
other
similarli
physic
reason
understand
stronger
bind
affin
rbd
protein
although
similar
zs
molecular
surfac
ca
time
larger
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
test
van
der
waal
vdw
contribut
compar
w
r
model
electrostat
interact
complet
switch
vdw
interact
consid
testcas
system
shown
figur
seen
hypothet
test
weaker
bind
affin
rbd
protein
comparison
confirm
argument
present
seen
figur
wild
type
structur
main
physic
chemic
reason
design
new
function
molecul
reduc
net
charg
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
gener
togeth
decreas
repuls
group
close
locat
hostpathogen
interfac
two
amino
acid
substitut
suggest
biolog
interfac
one
peripher
see
figur
mutat
z
new
molecul
label
drop
ph
ph
bind
affin
computerdesign
molecul
test
calcul
w
r
new
fragment
mab
given
figur
seen
abl
bind
equival
bind
affin
observ
system
decreas
recov
valu
found
case
see
figur
tabl
therefor
promis
design
mab
candid
care
systemat
examin
experiment
assay
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
refin
analysi
sequenc
level
proceedpka
method
employ
determin
ee
rbd
protein
relev
studi
complex
three
question
address
rbd
protein
share
common
bind
region
bind
viral
rbd
protein
interact
mab
use
similar
epitopeparatop
interfac
interact
involv
ee
data
answer
question
given
figur
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
figur
primari
sequenc
rbd
protein
plot
togeth
estim
ioniz
amino
acid
interfac
antigen
region
defin
proceedpka
method
differ
distribut
amino
acid
identifi
ee
shown
blue
seen
electrostat
method
sensit
structur
titrat
group
produc
electr
perturb
partner
interact
demonstr
pattern
observ
viral
sar
protein
similar
ie
share
common
region
bind
although
interest
observ
made
compar
number
ioniz
residu
involv
interact
rbd
protein
pair
see
increas
high
number
common
case
amino
acid
amino
acid
interact
viral
protein
differ
observ
neighbor
group
eg
awerkkisn
awnrkrisn
indic
biolog
interfac
explor
two
viral
rbd
protein
spite
structur
differ
rbd
protein
respons
clearli
titrat
residu
interact
precursor
observ
suggest
bind
might
less
specif
happen
presenc
ab
may
complet
block
interact
gener
seen
figur
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
common
case
region
affect
structur
differ
eg
dysvlynstffstfkcyg
dysvlynsasfstfkcyg
replac
amino
acid
physic
chemic
group
eg
e
enough
result
differ
interact
eg
kgddvrqia
rgdevrqia
perturb
titrat
group
take
account
hypothes
might
addit
contribut
improv
capabl
mab
interact
inhibit
rbd
protein
fact
experiment
work
tian
colleagu
show
bind
rbd
affect
might
molecular
basi
behavior
care
use
stronger
statement
due
limit
theoret
approach
sever
addit
issu
remain
investig
final
compar
ee
predict
aa
aa
interact
rbd
protein
see
figur
predict
ee
interact
essenti
one
observ
common
aa
impli
suggest
mutat
affect
antigen
region
anoth
particularli
interest
featur
computerdesign
molecul
number
ee
share
increas
might
amplifi
potenti
mab
candid
better
block
virushost
cell
interact
electrostat
method
data
shown
figur
detail
also
figur
free
energi
interact
calcul
sever
molecular
complex
involv
rbd
spike
protein
present
theoret
result
confirm
rbd
protein
similar
bind
affin
previous
report
experiment
studi
observ
acid
neutral
ph
regim
probabl
indic
medium
ph
relev
begin
viral
cell
invas
ph
seem
import
next
step
viral
infect
first
entri
level
direct
implic
drug
develop
sinc
propos
like
chloroquin
rais
cell
ph
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
analyz
interact
rbd
protein
rbd
specif
neutral
mab
allow
us
reproduc
experiment
result
mab
measur
affin
rbd
protein
bli
assay
also
one
higher
affin
quantifi
present
theoret
studi
moreov
could
map
electrostat
epitop
identifi
mab
tend
share
titrat
residu
like
residu
involv
interact
howev
rbd
protein
respons
clearli
titrat
residu
interact
precursor
suggest
bind
might
less
specif
explain
gener
difficulti
mab
experi
complet
block
interact
chargecharg
interact
found
good
simpl
descriptor
fast
screen
design
improv
mab
diagnost
therapeut
vaccin
theoret
approach
still
develop
identifi
three
amino
acid
substitut
increas
bind
affin
rbd
protein
respons
present
pandem
result
contribut
guid
design
new
function
high
specif
mab
provid
costandtimeeffect
comput
framework
toward
develop
better
diagnost
strategi
effect
treatment
andor
vaccin
work
support
part
de
amparo
pesquisa
estado
de
also
deepli
thank
resourc
provid
swedish
nation
infrastructur
comput
snic
nsc
also
pleasur
acknowledg
initi
discuss
zhenlin
yang
zhongshan
hospit
fudan
univers
china
also
provid
us
preliminari
model
structur
use
first
test
laaksonen
acknowledg
swedish
scienc
council
financi
support
partial
support
grant
ministri
research
innov
romania
cnc
uefiscdi
project
number
within
pncdi
iii
addit
detail
given
supplementari
materi
valu
free
energi
depth
interact
rbd
differ
partner
b
van
der
waal
contribut
free
energi
profil
interact
rbd
protein
two
monoclon
antibodi
tabl
valu
simul
free
energi
depth
interact
associ
rbd
protein
monoclon
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
antibodi
physiolog
salt
concentr
data
extract
figur
valu
given
kbt
unit
center
mass
rbd
protein
two
monoclon
antibodi
without
electrostat
contribut
detail
figur
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
